Effect of spirulina on Irritable bowel syndrome patients
Not Applicable
- Conditions
- Irritable bowel syndrome.Irritable bowel syndrome
- Registration Number
- IRCT20140208016529N8
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Ages range of 18-50 years
patients diagnosed with irritable bowel syndrome by gastroenterologist
Exclusion Criteria
Smoking
Alcohol consumption
Pregnancy or breastfeeding condition
Taking antidepressants and anxiety medications.
Taking antioxidant and omega-3 supplements in the last three months
Kidney, liver, thyroid and parathyroid, heart disease, cancer and gastrointestinal diseases other than IBS
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: At baseline and after 12 weeks. Method of measurement: Irritable bowel syndrome-quality of life- 34 (IBS-QOL-34)questionnaire.;Disease severity. Timepoint: At baseline and after 12 weeks. Method of measurement: Irritable bowel syndrome syndrome severity scale(IBS-SSS) questionnaire.;Serum zonulin level. Timepoint: At baseline and after 12 weeks. Method of measurement: Eliza kit.
- Secondary Outcome Measures
Name Time Method Total antioxidant capacity of serum. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.;Malonaldehyde. Timepoint: At baseline and after 12 weeks. Method of measurement: Colorimetric method.